A pandemic influenza vaccine in India: from strain to sale within 12 months.
about
Sociocultural determinants of anticipated acceptance of pandemic influenza vaccine in Pune, India: a community survey using mixed-methods.Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.Socioeconomic, cultural and behavioural features of prior and anticipated influenza vaccine uptake in urban and rural Pune district, India: a mixed-methods case studyEffectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine: a case control study.Community awareness, use and preference for pandemic influenza vaccines in Pune, IndiaMicroneedle and mucosal delivery of influenza vaccines.PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries.A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac (®) ) in India.Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern AsiaIntranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola VaccineIntranasal formulations: promising strategy to deliver vaccines.Current prospects and future challenges for nasal vaccine delivery.New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy.Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study.Are we asking the right ethics questions on drug shortages? Suggestions for a global and anticipatory ethics framework.Public Health Policy and Experience of the 2009 H1N1 Influenza Pandemic in Pune, India.
P2860
Q30151763-E7668A92-B459-4806-BB5E-62F39392D37DQ30151807-3FBA8859-FE25-46CD-BF99-DB217D54B686Q30223373-F8EB4208-0EA4-4CA8-AF94-7348DF061E60Q30357697-32D89FD6-6D5E-402E-A782-EDC31794E4BAQ30376060-1BA293A8-DA2A-4496-B58C-31C7F0A0044FQ30418015-175772BB-2F5A-4CC1-8046-440E0EF41976Q30421549-AD27612F-81B6-4D8C-8D62-A23210B8C8B9Q30427619-8880B4D8-CFFA-409E-9D72-F399DDCEBAD8Q33554718-740E498D-947E-443D-BCF4-A68EDAE0E990Q34309830-405E9F22-8A52-450A-AFAC-60704682A7F4Q35917496-8878E3D6-6B09-478A-992A-44DC025DF196Q38223050-BD5648DA-15FF-4C08-BB17-EA8D0B202AD0Q38784950-E0247F1D-20B7-4EAC-8AED-68AC9E8C18B9Q38883770-4DF34A41-D1F8-402A-8D77-5171910FDA19Q42696710-68751B93-C6D1-42ED-81BA-C0CA3B2F0CD9Q48502696-96C98832-C28C-4AFE-9004-98DA201D01B2Q50301024-137A1835-33FA-4BE4-B671-2E174CA6BC59
P2860
A pandemic influenza vaccine in India: from strain to sale within 12 months.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A pandemic influenza vaccine in India: from strain to sale within 12 months.
@ast
A pandemic influenza vaccine in India: from strain to sale within 12 months.
@en
type
label
A pandemic influenza vaccine in India: from strain to sale within 12 months.
@ast
A pandemic influenza vaccine in India: from strain to sale within 12 months.
@en
prefLabel
A pandemic influenza vaccine in India: from strain to sale within 12 months.
@ast
A pandemic influenza vaccine in India: from strain to sale within 12 months.
@en
P2093
P1433
P1476
A pandemic influenza vaccine in India: from strain to sale within 12 months.
@en
P2093
Leena Yeolekar
Milan Ganguly
Parikshit Tyagi
Prajakt Barde
Prasad Kulkarni
Rajeev Dhere
Ravi Menon
Suresh Jadhav
Vivek Vaidya
P304
P356
10.1016/J.VACCINE.2011.04.119
P407
P478
29 Suppl 1
P577
2011-07-01T00:00:00Z